Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway

克拉斯 癌症研究 体内 肺癌 PI3K/AKT/mTOR通路 蛋白激酶B 细胞凋亡 细胞生长 癌症 化学 药理学 医学 生物 内科学 结直肠癌 生物化学 生物技术
作者
Xuenan Hou,C. Zhou,Zuhui Liang,Huawei Qiu,Z.R. Zhou,Huilei Zheng,Zeyun Li,Ying Wang,Xiaoxiao Qi,Linlin Lu,Yang Cao,Jing Zheng
出处
期刊:Phytomedicine [Elsevier]
卷期号:121: 155093-155093 被引量:5
标识
DOI:10.1016/j.phymed.2023.155093
摘要

KRAS mutation is a common driver of NSCLC, and there is a high proportion of lung cancer patients with KRAS G12C and G12D mutation. KRAS was previously considered an "undruggable" target, but the first KRAS G12C mutation-targeted drug AMG510, entered the market in 2021. However, treatments for G12D mutant tumors remain to be discovered. Salvianolic acid F (SalF), a monomer derived from the traditional Chinese medicine Salvia miltiorrhiza (SM), and KRAS had high binding affinity, especially for KRAS G12D. There is an urgent need to investigate effective and safe novel targeted therapies against KRAS G12D-driven NSCLC.To evaluate the anticancer effect of SalF, we used KRAS-overexpressing lung cancer cells in vitro, a subcutaneous transplant tumor model, and KRAS G12D mice model in vivo. Then, the binding effect of SalF and KRAS was investigated using molecular docking, proteolytic assays and protein thermal shift assays. More critically, the PI3K/AKT signaling pathway in the lung was investigated utilizing RT-qPCR and Western Blotting.This is the first study to evaluate the anticancer effect of SalF on KRAS-overexpressing lung cancer cells or KRAS G12D lung tumors in vivo. We demonstrated that SalF inhibits OE-KRAS A549 cell migration, proliferation and promotes apoptosis in vitro. In addition, we used a subcutaneous transplant tumor model to show that SalF suppresses the growth of lung cancer cells in vivo. Interestingly, our group found that SalF was strongly bound to G12D and could decrease the stability and promoted the degradation of the KRAS G12D mutant through molecular docking, proteolytic assays and protein thermal shift assays. Further research demonstrated that in the KrasG12D mice model, after SalF treatment, the number and size of mouse lung tumors were significantly reduced. More importantly, SalF can promote apoptosis by inhibiting downstream PI3K/AKT signaling pathway activation.SalF activated apoptosis signaling pathways, suppressed anti-apoptotic genes, and inhibited lung cancer cell growth. These datas suggested that SalF could effectively inhibit the growth of lung tumors with KRAS G12D mutation. SalF may be a novel inhibitor against KRAS G12D, providing a strong theoretical basis for the clinical treatment of lung cancer with KRAS mutations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秀xiu发布了新的文献求助10
1秒前
8秒前
bkagyin应助尽我所能采纳,获得10
8秒前
澡雪完成签到,获得积分10
15秒前
wangfugui完成签到,获得积分10
15秒前
大个应助青瓜大王采纳,获得10
17秒前
18秒前
19秒前
19秒前
在水一方应助随便采纳,获得10
20秒前
21秒前
22秒前
尽我所能发布了新的文献求助10
22秒前
炫哥IRIS完成签到,获得积分10
24秒前
25秒前
宸一完成签到,获得积分10
25秒前
tzp完成签到,获得积分20
27秒前
beijiu完成签到 ,获得积分10
27秒前
29秒前
伈X发布了新的文献求助10
29秒前
天使小五哥应助wzwz采纳,获得10
30秒前
Meimei发布了新的文献求助50
32秒前
32秒前
Yuxiao关注了科研通微信公众号
33秒前
GXGXGX完成签到,获得积分20
33秒前
realrrr发布了新的文献求助10
35秒前
36秒前
ccCherub完成签到,获得积分10
36秒前
CodeCraft应助石会发采纳,获得10
36秒前
37秒前
随便完成签到,获得积分10
37秒前
38秒前
大个应助GXGXGX采纳,获得10
39秒前
43秒前
十七发布了新的文献求助20
44秒前
sussiczdh完成签到,获得积分10
45秒前
47秒前
47秒前
称心翠容完成签到,获得积分10
47秒前
47秒前
高分求助中
Sustainability in ’Tides Chemistry 1500
The ACS Guide to Scholarly Communication 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
Historia de la ciencia jurídica europea 600
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3069575
求助须知:如何正确求助?哪些是违规求助? 2723483
关于积分的说明 7481948
捐赠科研通 2370550
什么是DOI,文献DOI怎么找? 1257057
科研通“疑难数据库(出版商)”最低求助积分说明 609800
版权声明 596861